Abstract
Histone deacetylase (HDAC) inhibitors sodium butyrate and trichostatin A arrest human papillomavirus (HPV)-positive carcinoma cells in G1 to S transition of the cell cycle, which is paralleled by an up-regulation of the cyclin-dependent kinase inhibitors (CKIs) p21CIP1 and p27KIP1 as well as the complete loss of cdk2 activity. Although HPV expression was hitherto thought to be required to maintain a proliferative phenotype of these cells, cdk2 suppression is achieved even in the presence of ongoing viral transcription. While CKIs normally cannot exert their cdk2-inhibitory function in the presence of the viral oncoprotein E7, co-immunoprecipitation experiments revealed that E7 binding is prevented. Increase of p27KIP1 correlates with down-regulation of p45SKP2, a component of the ubiquitin-protein ligase SCFSKP2 controlling the half-life of regulatory proteins during the cell cycle. HDAC inhibition also triggered an E7-dependent degradation of pRb, while the levels of E2F remained unaffected. The presence of free intracellular E2F and the concomitant up-regulation of CKIs during G1 arrest results in a ‘conflicting growth situation’, which finally renders the cells to undergo apoptosis. These data provide novel molecular insights into how the transforming potential of HPV can be bypassed and open new therapeutical perspectives for the treatment of cervical cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Almasan A, Yin Y, Kelly RE, Lee EY-HP, Bradley A, Li W, Bertino JR, Wahl GM . 1995 Proc. Natl. Acad. Sci. USA 92: 5436–5440
Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G . 1993 Genes Dev. 7: 812–821
Blomberg I, Hoffmann I . 1999 Mol. Cell. Biol. 19: 6183–6194
Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H . 1984 EMBO J. 3: 1151–1157
Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1998 Nature 391: 597–601
Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1999 EMBO J. 18: 2449–2458
Carnero A, Hannon GJ . 1998 Curr. Top. Microbiol. Immunol. 227: 43–55
Carrano AC, Eytan E, Hershko A, Pagano M . 1999 Nat. Cell Biol. 1: 193–199
Chomczynski P, Sacchi N . 1987 Anal. Biochem. 162: 156–159
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Ercolani L, Florence B, Denaro M, Alexander M . 1988 J. Biol. Chem. 263: 15335–15341
Feinberg A, Vogelstein BA . 1984 Anal. Biochem. 137: 266–267
Finzer P, Soto U, Delius H, Patzelt A, Coy JF, Poustka A, zur Hausen H, Rösl F . 2000 Oncogene 19: 3235–3244
Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung YK, Israel MA . 1995 EMBO J. 14: 461–472
Hengst L, Reed SI . 1998 Curr. Top. Microbiol. Immunol. 227: 25–41
Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA . 1992 Cell 70: 993–1006
Hofmann F, Martelli F, Livingston DM, Wang Z . 1996 Genes Dev. 10: 2949–2959
Janson W, Brandner G, Siegel J . 1997 Oncogene 15: 1395–1406
Jones DL, Münger K . 1996 Semin. Cancer Biol. 7: 327–337
Lallemand F, Courilleau D, Sabbah M, Redeuilh G, Mester J . 1996 Biochem. Biophys. Res. Commun. 229: 163–169
Luo RX, Postigo AA, Dean DC . 1998 Cell 92: 463–473
Marti A, Wirbelauer C, Scheffner M, Krek W . 1999 Nat. Cell Biol. 1: 14–19
Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T . 2000 EMBO J 19: 662–671
Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K . 2001 Genes Dev. 15: 267–285
Nakayama K, Nagahama H, Minamishima Y, Matsumoto M, Nakamichi Il, Kitagawa K, Shirane M, Tsunematsu R, Tsukiyama T, Ishida N, Kitagawa M., Nakayama K-i, Hatakeyama S . 2000 EMBO J. 19: 2069–2081
Newmark HL, Lupton JR, Young CW . 1994 Cancer Lett. 78: 1–5
Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G . 1992 EMBO J. 11: 961–971
Park J-S, Kim E-J, Kwon H-J, Hwang E-S, Namkoong S-E, Um S-J . 2000 J. Biol. Chem. 275: 6764–6769
Parthun MR, Widom J, Gottschling DE . 1996 Cell 87: 85–94
Patel D, Huang S-M, Baglia LA, McCance DJ . 1999 EMBO J. 18: 5061–5072
Pines J, Hunter T . 1990 Nature 346: 760–763
Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J . 1994 Cell 78: 59–66
Rösl F, Kleine-Lowinski K, zur Hausen H . 1999 The possible role of chemokines in HPV-linked carcinogenesis. Rollins BJ. (ed.)Humana Press Inc., Totowa, NJ pp. 207–225
Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP . 1996 Nature 382: 325–331
Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, Xu H, Cohen D . 1999 J. Biol. Chem. 274: 34940–34947
Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . 1990 Cell 63: 1129–1136
Sherr CJ . 1993 Cell 73: 1059–1065
Sherr CJ . 1996 Science 274: 1672–1677
Siavoshian S, Blottiere HM, Cherbut C, Galmiche J-P . 1997 Biochem. Biophys. Res. Commun. 232: 169–172
Stoehr M, Vogt-Schaden M, Knobloch M, Vogel R, Futtermann G . 1978 Stain Technol. 55: 205–215
Sutterlüty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Müller U, Krek W . 1999 Nat. Cell Biol. 1: 207–214
Tommasino M, Adamczewski JP, Carlotti F, Barth CF, Manetti R, Contorni M, Cavalieri F, Hunt T, Crawford L . 1993 Oncogene 8: 195–202
Wade PA, Pruss D, Wolffe AP . 1997 Trends Biochem. Sci. 22: 128–132
von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L . 1988 Cancer Res. 48: 3780–3786
Weinberg RA . 1995 Cell 81: 323–330
Workman JL, Kingston RE . 1998 Annu. Rev. Biochem. 67: 545–579
Wu C . 1997 J. Biol. Chem. 272: 28171–28174
Xiao H, Hasegawa T, Isobe K-I . 2000 J. Biol. Chem. 275: 1371–1376
Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Dürr P . 1995 J. Virol. 69: 6389–6399
Zerfass-Thome K, Schulze A, Zwerschke W, Vogt B, Helin K, Bartek J, Henglein B, Jansen-Dürr P . 1997 J. Virol. 17: 407–415
Zhang H, Hannon GJ, Beach D . 1994 Genes Dev. 8: 1750–1758
Zhang H, Kobayashi R, Galaktionov K, Beach D . 1995 Cell 82: 915–925
Zur Hausen H . 2000 J. Natl. Cancer Inst. 92: 690–698
Acknowledgements
The authors are grateful to our colleagues for providing plasmid probes and biochemical reagents. We are also grateful to N Whitaker (University of New South Wales, Sydney, Australia) for giving us the HPV16-immortalized human keratinocytes. The excellent technical support of Nadine Seibert and Christina Weber is appreciated. We also thank Michael Stoehr (DKFZ, Heidelberg) for his help in FACS analysis and Leslie Thomas for carefully reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Finzer, P., Kuntzen, C., Soto, U. et al. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene 20, 4768–4776 (2001). https://doi.org/10.1038/sj.onc.1204652
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204652
Keywords
This article is cited by
-
Nuclear oligo hashing improves differential analysis of single-cell RNA-seq
Nature Communications (2022)
-
Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line
Tumor Biology (2016)
-
Human papillomavirus and lung cancinogenesis: an overview
Journal of Cancer Research and Clinical Oncology (2016)
-
Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis
Current Obstetrics and Gynecology Reports (2014)
-
Dual effects of sodium butyrate on hepatocellular carcinoma cells
Molecular Biology Reports (2012)